Structure-activity relationships of low molecular weight heparins expose to the risk of achieving inappropriate targets in patients with renal failure.
Authors:
Stratta P, Karvela E, Canavese C, Quaglia M, Lazzarich E, Fenoglio R, Pergolini P, Bellomo G, Cena T, Magnani C.
Source:
Curr Med Chem 2009; 16: 3028-40.